Global Endobronchial Ultrasound Biopsy Market

Endobronchial Ultrasound Biopsy Market Summary

The Global Endobronchial Ultrasound Biopsy Market Size Was Estimated at USD 689.4 Million in 2024 and is Projected to Reach USD 1378.6 Million by 2035, Growing at a CAGR of 6.5% from 2025 to 2035. The market for endobronchial ultrasound biopsies is expanding due to technical developments, increased desire for minimally invasive procedures, an increase in lung cancer cases, and better diagnostic accuracy in the treatment of pulmonary diseases.

Key Regional and Segment-Wise Insights

• In 2024, North America held the largest revenue share of 28.53% and dominated the market globally.
• With a market share of more than 32.5% in 2024, the EBUS scopes segment led the market by product.
• In 2024, the hospitals segment held the largest market share of 41.5% and led the market by end use.

Global Market Forecast and Revenue Outlook

• 2024 Market Size: USD 689.4 Million
• 2035 Projected Market Size: USD 1378.6 Million
• CAGR (2025-2035): 6.5%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

The market for endobronchial ultrasound (EBUS) biopsies represents a medical domain that specializes in advanced techniques for extracting tissue and fluid samples from pulmonary structures and adjacent lymphatic nodes. Lung cancer and infections, alongside various other lymph node enlargement conditions, are diagnosed through EBUS biopsy procedures. The market growth stems from rising lung cancer rates and respiratory disease cases, along with the global shift toward precise early diagnosis and minimally invasive procedures, which reduce hospital time and recovery duration. The market shows growth because healthcare providers better understand EBUS-guided biopsies and because more healthcare facilities across different countries use these techniques.

Technological advancements have led to substantial improvements that make EBUS biopsy operations more precise and effective.  The combination of real-time imaging, together with enhanced ultrasound probes and artificial intelligence implementation in diagnostic equipment, has resulted in safer and more reliable procedures. The market experiences growth due to supportive government initiatives, which include cancer research funding, public health promotion, and simplified access to modern diagnostic tools. The various technological developments have established EBUS biopsies as an indispensable tool in modern respiratory diagnostic procedures.

Product Insights

How Did the EBUS Scopes Segment Achieve Market Leadership in the Endobronchial Ultrasound Biopsy Market in 2024?

In 2024, the EBUS scopes segment accounted for the largest revenue share of 32.5% and led the endobronchial ultrasound biopsy market. The critical role of EBUS scopes in real-time imaging and sampling of hilar and mediastinal lymph nodes stands as the main reason for their market dominance. Patients choose these devices to diagnose infections, together with lung cancer and thoracic conditions, because they deliver precise results and improved imaging, along with ultrasound technology integration. The rising number of diagnostic procedures, along with the deployment of advanced imaging technologies in hospitals and specialty clinics, drives market demand. The strong market position of this category will continue through ongoing scope design innovations, together with increasing public awareness about detecting cancer at an early stage.

The EBUS-TBNA needles and dedicated biopsy consumables segment of the endobronchial ultrasound biopsy market is anticipated to grow at the fastest CAGR during the forecast period. The increasing popularity of EBUS-guided transbronchial needle aspiration (TBNA) techniques for accurate minimally invasive lymph node and lung mass sampling drives this market expansion. The rising requirement for precise diagnosis has caused enhanced demand for specialized needles together with high-quality single-use biopsy supplies. These products decrease contamination risks while simultaneously improving diagnostic results and enhancing procedural safety. The fast growth of this market segment emerges from ongoing needle material and design enhancements combined with growing clinician understanding about their therapeutic benefits across both developed and developing nations.

End Use Insights

Why Did the Hospitals Segment Hold the Highest Revenue Share of 41.5% in the Endobronchial Ultrasound Biopsy Market in 2024?

The hospitals segment held the highest revenue share of 41.5% and led the endobronchial ultrasound biopsy market in 2024. The numerous diagnostic procedures, together with interventional procedures performed within hospital facilities, along with advanced medical equipment and expert healthcare personnel, create this market leadership. Hospitals serve as primary centers for diagnosing and treating complex respiratory diseases, including lung cancer, where EBUS-guided biopsies are gaining popularity due to their precision and minimally invasive nature. Hospitals tend to adopt cutting-edge technology, which includes specialized biopsy consumables and EBUS scopes, thus growing their market presence. This market leader position stems from increasing healthcare funding along with expanding patient populations.

During the forecast period, the ambulatory surgical centers (ASCs) segment of the endobronchial ultrasound biopsy market is anticipated to grow at the fastest CAGR. The growing popularity of outpatient minimally invasive procedures with shorter recovery times, reduced hospital stays, and lower costs drives this rapid expansion. ASCs now incorporate modern EBUS systems, which enable them to perform complex diagnostic procedures, including EBUS-TBNA, with safety and efficiency. The increasing patient and clinician preference for ASCs stems from healthcare's decentralized care delivery as well as favorable payment models and faster procedure duration. The market demonstrates excellent potential for substantial expansion within this area.

Regional Insights

North America led the endobronchial ultrasound (EBUS) biopsy market globally with the largest revenue share of 28.53% in 2024. The sophisticated medical infrastructure, together with extensive adoption of minimally invasive diagnostics and increasing respiratory disease cases, including lung cancer, propels North America's market leadership.  The market expansion continues because of prominent market players along with ongoing innovations in EBUS systems and biopsy tools.  The increasing number of EBUS-guided biopsies can be attributed to reimbursement programs that support these procedures and heightened knowledge among healthcare providers regarding their benefits. The United States and Canada receive strong government backing for cancer research, together with programs that focus on early detection, which helps maintain North America's market supremacy.

Europe Endobronchial Ultrasound Biopsy Market Trends

The European market for endobronchial ultrasound (EBUS) biopsies experiences substantial growth because of the rising numbers of respiratory illnesses and lung cancer, together with the need for minimally invasive diagnostic procedures.  The area benefits from having skilled medical staff and developed healthcare networks, and a growing public understanding of early cancer detection methods. Germany, the UK, and France stand at the forefront when it comes to adopting advanced diagnostic technologies such as EBUS-TBNA. Public health initiatives and modernized healthcare facilities, along with supportive governmental regulations, drive accelerated market expansion. Patient outcome improvements alongside procedural risk reduction efforts will propel the European market toward sustained growth during the forecast period.

Asia Pacific Endobronchial Ultrasound Biopsy Market Trends

The Asia-Pacific endobronchial ultrasound (EBUS) biopsy market will experience the fastest CAGR in the forecast period. The major expansion drivers are healthcare infrastructure development, combined with increasing respiratory disease cases and lung cancer incidents, and rising recognition of precise diagnostic methods. EBUS biopsy and other minimally invasive procedures are gaining popularity across Chinese, Indian, Japanese, and South Korean healthcare systems because they enhance patient recovery speed and diagnostic accuracy. The expansion of the market results from rising healthcare expenses, along with government cancer treatment initiatives and increasing medical device manufacturing within this region. The Asia-Pacific region demonstrates rapid market growth because medical professionals reside here in sufficient numbers, and medical tourism growth enables the swift implementation of modern diagnostic technologies.

Key Endobronchial Ultrasound Biopsy Companies:

The following are the leading companies in the endobronchial ultrasound biopsy market. These companies collectively hold the largest market share and dictate industry trends.

• GE Healthcare
• ACE Medical Devices Pvt. Ltd.
• Cook Group Incorporated
• Siemens Healthcare Private Limited
• FUJIFILM Holdings Corporation
• Boston Scientific Corporation
• Olympus Corporation
• Medi-Globe Technologies GmbH
• Koninklijke Philips N.V.
• Praxis Medical
• Others

Recent Developments

• In January 2025, by purchasing the distribution business from Sur Medical SpA in Chile, Olympus America has made it possible for Olympus Latin America to use its recently formed local company to directly sell, distribute, and service its entire array of medical technologies in the market.

• In September 2024, FUJIFILM Healthcare Europe GmbH revealed that a linear bronchoscope and several ultrasonic endoscopes are compatible with their ARIETTA 750 FF ENDO ultrasound system.  This system includes cutting-edge technologies like "Carving Imaging" for better visualization and "eFocusing" for sharper images.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decision Advisor  has segmented the endobronchial ultrasound biopsy market based on the below-mentioned segments:  

Global Endobronchial Ultrasound Biopsy Market, By Product

• EBUS Scopes
• EBUS-TBNA Needles & Dedicated Biopsy Consumables
• Ultrasound Processors and Imaging Systems
• Accessories & Ancillaries

Global Endobronchial Ultrasound Biopsy Market, By End Use

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics

Global Endobronchial Ultrasound Biopsy Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa